Table: Stella Pharma -2021/22 parent forecast

Stella Pharma

06/05/2022 07:20

May 6 (Reuters) -
              Stella Pharma Corporation     
              PARENT- ONLY EARNINGS ESTIMATES
  (in billions of yen unless specified)                    
                 Full Year to      Full Year to 
               Mar 31, 2022      Mar 31, 2022   
                  LATEST           PREVIOUS     
                 FORECAST          FORECAST     
  Sales           100 mln           123 mln     
  Operating    loss 741 mln      loss 775 mln   
  Recurring    loss 764 mln      loss 827 mln   
  Net          loss 767 mln      loss 831 mln   
  EPS         loss 27.34 yen    loss 29.60 yen  
 
  NOTE - Stella Pharma Corporation.    
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4888.T